Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole-Mg 80 mg vs Pantoprazole-Na 40 mg for healing of severe reflux esophagitis
2004-000492-33Phase 3Completed
- Sponsor
- Altana Pharma
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of pantoprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Altana Pharma. Started Aug 2004; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2004-000492-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000492-33.